SC
Stempoint Capital Portfolio holdings
AUM
$583M
1-Year Est. Return
185.08%
This Fund
S&P 500
1 Year Est. Return
+185.08%
AUM
$496M
AUM Growth
+$185M
(+60%)
Holding
92
Top Buys
| 1 | +$44.5M | |
| 2 | +$14.8M | |
| 3 | +$12.3M | |
| 4 |
Wave Life Sciences
WVE
|
+$9.79M |
| 5 |
argenx
ARGX
|
+$8.22M |
Top Sells
| 1 | +$16.6M | |
| 2 | +$14M | |
| 3 | +$13.7M | |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$13.2M |
| 5 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$10.8M |
Sector Composition
| 1 | Healthcare | 99.22% |
| 2 | Financials | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVA
76
Inventiva
IVA
$1.25B
| $178K | 0.04% |
+30,824
|
|
||
77
State Street SPDR S&P Biotech ETF
XBI
$8.31B
| – | – |
0
|
|
||
78
Apogee Therapeutics
APGE
$4.88B
| – | – |
-84,466
|
|
||
79
ARK Genomic Revolution ETF
ARKG
$1.23B
| – | – |
0
|
|
||
80
Geron
GERN
$938M
| – | – |
-6,649,244
|
|
||
81
CRISPR Therapeutics
CRSP
$5.78B
| – | – |
0
|
|
||
82
EyePoint Inc
EYPT
$1.49B
| – | – |
-329,254
|
|
||
83
Ionis Pharmaceuticals
IONS
$12.9B
| – | – |
0
|
|
||
84
Janux Therapeutics
JANX
$862M
| – | – |
-89,933
|
|
||
85
Legend Biotech
LEGN
$3.36B
| – | – |
-270,144
|
|
||
|
MRUS
86
DELISTED
Merus
MRUS
| – | – |
-266,094
|
|
||
87
Nuvalent
NUVL
$8.06B
| – | – |
-59,828
|
|
||
88
Praxis Precision Medicines
PRAX
$9.15B
| – | – |
-32,255
|
|
||
89
Regeneron Pharmaceuticals
REGN
$83.3B
| – | – |
-4,672
|
|
||
|
VRNA
90
DELISTED
Verona Pharma
VRNA
| – | – |
-7,407
|
|
||
91
Zai Lab
ZLAB
$2.18B
| – | – |
-250,438
|
|
||
|
LENZ
92
LENZ Therapeutics
LENZ
$406M
| – | – |
-183,912
|
|